-
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial
Moolenaar, L. R., Ali, M., Aufenacker, T. J., Beets, G. L., Bosker, R. J. I., Buffart, T. E., Burger, J. W. A., Dekker, E., Denost, Q., Doornebosch, P. G., Duijvendijk, P. V., Fabry, H. F. J., Geijsen, E. D., Gerhards, M. F., van Grevenstein, W. M. U., Grotenhuis, B. A., Hoff, C., Leijtens, J. W. A., Peeters, K. C. M. J. & Pronk, A. & 99 others, , Jul 2026, In: The Lancet Gastroenterology and Hepatology. 11, 7, p. 557-569 13 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Functional outcomes and quality of life following open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in rectal cancer patients: a systematic review and meta-analysis
The MIRECA Study Group, Aug 2024, In: Surgical Endoscopy. 38, 8, p. 4431-4444 14 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Epidemiology and risk factors of sudden cardiac arrest
Zimmerman, D. S. & Tan, H. L., 1 Dec 2021, In: Current Opinion in Critical Care. 27, 6, p. 613-616 4 p.Research output: Contribution to Journal › Review article › Academic › peer-review
- All publications